Related Experiment Videos
Fibromyalgia and interleukin-2 therapy for malignancy
Annals of Internal Medicine
|June 1, 1988
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities.
Annals of the rheumatic diseases·2020
Geographic access to buprenorphine prescribers for patients who use public transit.
Journal of substance abuse treatment·2020
Non-coding RNAs - A primer for the laboratory scientist.
British journal of biomedical science·2019
Glucagon-Like Peptide-1 Receptor Agonists and Risk for Ischemic Optic Neuropathy : A Target Trial Emulation.
Annals of internal medicine·2026
Modernizing the Regulatory Framework for Dietary Supplements: A Position Paper From the American College of Physicians.
Annals of internal medicine·2026
Obstructive Sleep Apnea.
Annals of internal medicine·2026
Glucagon-like Peptide-1 Receptor Agonists and Risk for Anterior Ischemic Optic Neuropathy : A Nationwide Cohort Study.
Annals of internal medicine·2026
The Role of Telemedicine on Interhospital Transfer Outcomes : A Systematic Review.
Annals of internal medicine·2026
Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.
Case reports in dermatological medicine·2026
Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.
Frontiers in endocrinology·2026
Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.
Kidney diseases (Basel, Switzerland)·2026
Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.
Frontiers in cell and developmental biology·2026